
Halozyme Therapeutics
Halozyme Therapeutics develops extracellular matrix targeting products for the insulin, cancer, dermatology and drug delivery markets.
HQ location
San Diego, United States
Website
Launch date
Employees
Market cap
$6.4b
Authorizing premium user...